These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 11462805)
1. The A3 adenosine receptor induces cytoskeleton rearrangement in human astrocytoma cells via a specific action on Rho proteins. Abbracchio MP; Camurri A; Ceruti S; Cattabeni F; Falzano L; Giammarioli AM; Jacobson KA; Trincavelli L; Martini C; Malorni W; Fiorentini C Ann N Y Acad Sci; 2001 Jun; 939():63-73. PubMed ID: 11462805 [TBL] [Abstract][Full Text] [Related]
2. The A3 adenosine receptor mediates cell spreading, reorganization of actin cytoskeleton, and distribution of Bcl-XL: studies in human astroglioma cells. Abbracchio MP; Rainaldi G; Giammarioli AM; Ceruti S; Brambilla R; Cattabeni F; Barbieri D; Franceschi C; Jacobson KA; Malorni W Biochem Biophys Res Commun; 1997 Dec; 241(2):297-304. PubMed ID: 9425266 [TBL] [Abstract][Full Text] [Related]
3. Adenosine A Abbracchio MP; Ceruti S; Brambilla R; Barbieri D; Camurri A; Franceschi C; Giammarioli AM; Jacobson KA; Cattabeni F; Malorni W Drug Dev Res; 1998; 45(3-4):379-386. PubMed ID: 38239500 [TBL] [Abstract][Full Text] [Related]
5. Effects of synthetic A3 adenosine receptor agonists on cell proliferation and viability are receptor independent at micromolar concentrations. Mlejnek P; Dolezel P; Frydrych I J Physiol Biochem; 2013 Sep; 69(3):405-17. PubMed ID: 23184730 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological analysis of calcium responses mediated by the human A3 adenosine receptor in monocyte-derived dendritic cells and recombinant cells. Fossetta J; Jackson J; Deno G; Fan X; Du XK; Bober L; Soudé-Bermejo A; de Bouteiller O; Caux C; Lunn C; Lundell D; Palmer RK Mol Pharmacol; 2003 Feb; 63(2):342-50. PubMed ID: 12527805 [TBL] [Abstract][Full Text] [Related]
7. A3 adenosine receptors in human astrocytoma cells: agonist-mediated desensitization, internalization, and down-regulation. Trincavelli ML; Tuscano D; Marroni M; Falleni A; Gremigni V; Ceruti S; Abbracchio MP; Jacobson KA; Cattabeni F; Martini C Mol Pharmacol; 2002 Dec; 62(6):1373-84. PubMed ID: 12435805 [TBL] [Abstract][Full Text] [Related]
8. Activation of hippocampal adenosine A3 receptors produces a desensitization of A1 receptor-mediated responses in rat hippocampus. Dunwiddie TV; Diao L; Kim HO; Jiang JL; Jacobson KA J Neurosci; 1997 Jan; 17(2):607-14. PubMed ID: 8987783 [TBL] [Abstract][Full Text] [Related]
9. P-glycoprotein mediates resistance to A3 adenosine receptor agonist 2-chloro-N6-(3-iodobenzyl)-adenosine-5'-n-methyluronamide in human leukemia cells. Mlejnek P; Dolezel P; Kosztyu P J Cell Physiol; 2012 Feb; 227(2):676-85. PubMed ID: 21520073 [TBL] [Abstract][Full Text] [Related]
10. Selective activation of A3 adenosine receptors with N6-(3-iodobenzyl)adenosine-5'-N-methyluronamide protects against myocardial stunning and infarction without hemodynamic changes in conscious rabbits. Auchampach JA; Rizvi A; Qiu Y; Tang XL; Maldonado C; Teschner S; Bolli R Circ Res; 1997 Jun; 80(6):800-9. PubMed ID: 9168782 [TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis in rat cardiocytes by A3 adenosine receptor activation and its suppression by isoproterenol. Shneyvays V; Jacobson KA; Li AH; Nawrath H; Zinman T; Isaac A; Shainberg A Exp Cell Res; 2000 May; 257(1):111-26. PubMed ID: 10854059 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of adenosine receptors in PGT-beta mouse pineal gland tumour cells. Suh BC; Kim TD; Lee JU; Seong JK; Kim KT Br J Pharmacol; 2001 Sep; 134(1):132-42. PubMed ID: 11522605 [TBL] [Abstract][Full Text] [Related]
13. Roles of BCL-2 and caspase 3 in the adenosine A3 receptor-induced apoptosis. Appel E; Kazimirsky G; Ashkenazi E; Kim SG; Jacobson KA; Brodie C J Mol Neurosci; 2001 Dec; 17(3):285-92. PubMed ID: 11859924 [TBL] [Abstract][Full Text] [Related]
14. Adenosine A3 receptors on human eosinophils mediate inhibition of degranulation and superoxide anion release. Ezeamuzie CI; Philips E Br J Pharmacol; 1999 May; 127(1):188-94. PubMed ID: 10369472 [TBL] [Abstract][Full Text] [Related]
15. Activation of adenosine low-affinity A3 receptors inhibits the enteric short interplexus neural circuit triggered by histamine. Bozarov A; Wang YZ; Yu JG; Wunderlich J; Hassanain HH; Alhaj M; Cooke HJ; Grants I; Ren T; Christofi FL Am J Physiol Gastrointest Liver Physiol; 2009 Dec; 297(6):G1147-62. PubMed ID: 19808660 [TBL] [Abstract][Full Text] [Related]
16. The A3 adenosine receptor as a new target for cancer therapy and chemoprotection. Fishman P; Bar-Yehuda S; Barer F; Madi L; Multani AS; Pathak S Exp Cell Res; 2001 Oct; 269(2):230-6. PubMed ID: 11570815 [TBL] [Abstract][Full Text] [Related]
17. Adenosine A3 agonist cardioprotection in isolated rat and rabbit hearts is blocked by the A1 antagonist DPCPX. Kilpatrick EL; Narayan P; Mentzer RM; Lasley RD Am J Physiol Heart Circ Physiol; 2001 Aug; 281(2):H847-53. PubMed ID: 11454590 [TBL] [Abstract][Full Text] [Related]
18. Suppression of macrophage inflammatory protein (MIP)-1alpha production and collagen-induced arthritis by adenosine receptor agonists. Szabó C; Scott GS; Virág L; Egnaczyk G; Salzman AL; Shanley TP; Haskó G Br J Pharmacol; 1998 Sep; 125(2):379-87. PubMed ID: 9786512 [TBL] [Abstract][Full Text] [Related]
19. Balance of purines may determine life or death of retinal ganglion cells as A3 adenosine receptors prevent loss following P2X7 receptor stimulation. Zhang X; Zhang M; Laties AM; Mitchell CH J Neurochem; 2006 Jul; 98(2):566-75. PubMed ID: 16805847 [TBL] [Abstract][Full Text] [Related]
20. A role for central A3-adenosine receptors. Mediation of behavioral depressant effects. Jacobson KA; Nikodijević O; Shi D; Gallo-Rodriguez C; Olah ME; Stiles GL; Daly JW FEBS Lett; 1993 Dec; 336(1):57-60. PubMed ID: 8262217 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]